Abstract
Despite the increasing effects of regional urbanisation in most of sub-Saharan Africa, infection still remains a leading cause of morbidity and mortality, and it accounts for 30% of all cancers in the region. The young are more commonly affected compared to the older age group in developed countries. Viruses are the most implicated organisms, and the prevalence of HIV in the sub-region has emerged as a major co-factor in cancer development. As most of these infections are preventable, the use of vaccines against carcinogenic infections has proven to be effective in reducing the incidence of majority of these group of cancers. Additionally, early detection and targeted intervention have significantly reduced the burden of infection-related cancers worldwide. While these programs have been successfully incorporated into the health care systems of industrialised nations, limited resources and a lack of tangible indicators of success have limited their effective implementation in sub-Saharan Africa. Measures aimed at increasing awareness of these cancers, effective progress evaluation, and policy-driven prioritisation of cancer prevention and treatment in the sub-region will effectively reduce their incidence and associated morbidity and mortality.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Allain J. Screen and treat for chronic hepatitis B: an overdue issue for sub-Saharan Africa. Lancet. 2016;4(8):e507–8.
Bayo S, Bosch FX, de Sanjose S, et al. Risk factors of invasive cervical cancer in Mali. Int J Epidemiol. 2002;31:202–9.
Bray F, Jemal A, Grey N, Ferlay J, Forman D. Global cancer transitions according to the human development index (2008–2030): a population-based study. Lancet Oncol. 2012;13(8):790–801.
Bray F, Ren JS, Masuyer E, Ferlay J. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer. 2013;132(5):1133–45.
Butel J. Viral carcinogenesis: revelation of molecular mechanisms and etiology of human disease. Carcinogenesis. 2000;21(3):405–26.
Cancian L, Hansen A, Boshoff C. Cellular origin of Kaposi’s sarcoma and Kaposi’s sarcoma-associated herpesvirus-induced cell reprogramming. Trends Cell Biol. 2013;23:421–32.
Carpenter LM, Newton R, Casabonne D, et al. Antibodies against malaria and Epstein-Barr virus in childhood Burkitt lymphoma: a case-control study in Uganda. Int J Cancer. 2008;122(6):1319–23.
Casper C. The increasing burden of HIV-associated malignancies in resource-limited regions. Annu Rev Med. 2011;62:157–70.
Chene A, Donati D, Guerreiro-Cacais AO, et al. A molecular link between malaria and Epstein-Barr virus reactivation. PLoS Pathog. 2007;3(6):e80.
Clifford GM, Gallus S, Herrero R, et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet. 2005;366:991–8.
Colley DG, Bustinduy AL, Secor WE, King CH. Human schistosomiasis. Lancet. 2014;383:2253–64.
de Martel C, Ferlay J, Franceschi S, Vignat J, Bray F, Forman D, et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol. 2012;13(6):607–15.
de-The G. Is Burkitt’s lymphoma related to perinatal infection by Epstein-Barr virus? Lancet. 1977;1(8007):335–8.
Ferlay J, Shin HR, Bray F, Forman D, Mathers CD, Parkin D. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893–917.
Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86.
Finocchario-Kessler S, Wexler C, Maloba M, et al. Cervical cancer prevention and treatment research in Africa: a systematic review from a public health perspective. BMC Women’s Health. 2016;16(1):29.
Flint JS, Enquist LW, Racaniello VR, Skalka AM, editors. Principles of virology: infection of a susceptible host. Washington, DC: American Society of Microbiology; 2009. p. 191.
Fulford AJ, Ouma JH, Kimani G, Dunne DW. Puberty and age-related changes in susceptibility to schistosome infection. Parasitol Today. 1998;14(1):23–6. doi:10.1016/S0169-4758(97)01168-X.
Ganem D. KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine. J Clin Invest. 2010;120:939–49.
Halec G, Alemany L, Lloveras B, Schmitt M, Alejo M, Bosch FX, et al. Pathogenic role of the eight probably/possibly carcinogenic HPV types 26, 53, 66, 67, 68, 70, 73 and 82 in cervical cancer. J Pathol. 2014;234(4):441–51.
Herrero R, Franceschi S. Vaccination. In: Stewart BW, Wild C, editors. World cancer report. Lyon: International Agency for Research on Cancer; 2014. p. 314–21.
Hjalgrim H, Friborg J, Melbye M. The epidemiology of EBV and its association with malignant disease. In: CBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health, Arvin A, Campadelli-Fiume G, Mocarski E, et al., editors. Human herpesviruses: biology, therapy, and immunoprophylaxis. Cambridge: Cambridge University Press; 2007.
Howell J, Ladep NG, Lemoine M, et al. Hepatitis B in sub-Saharan Africa. S Sudan Med J. 2014;7(3):59–61.
Jemal A, Bray F, Forman D, O’Brien M, Ferlay J, Center M, et al. Cancer burden in Africa and opportunities for prevention. Cancer. 2012;118(18):4372–84.
Kamal SM, El Sayed Khalifa K. Immune modulation by helminthic infections: worms and viral infections. Parasite Immunol. 2006;28:483–96.
Lancet Editorial. HPV vaccination: a decade on. Lancet. 2016;388(10043):438.
Lemoine M, Shimakawa Y, Njie R, et al. Acceptability and feasibility of screen-and-treat program for hepatitis B virus infection in the Gambia: the prevention of liver fibrosis and cancer in Africa (PROLIFICA) study. Lancet Glob Health. 2016;4(8):e559–67.
Lewis N, Young J, Hesseling PB, McCormick P, Wright N. Epidemiology of Burkitt’s lymphoma in Northwest Province, Cameroon, 2003–2010. Paediatr Int Child Health. 2012;32(2):82–5.
Liao JB. Viruses and human cancer. Yale J Biol Med. 2006;79:115–22.
Mabula JB, McHembe MD, Koy M, Chalya PL, Massaga F, Rambau PF, et al. Gastric cancer at a university teaching hospital in northwestern Tanzania: a retrospective review of 232 cases. World J Surg Oncol. 2012;10:257.
Martin JN. Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 and Kaposi sarcoma. Adv Dent Res. 2011;23:76–8.
Mbulaiteye SM, Bhatia K, Adebamowo C, Sasco AJ. HIV and cancer in Africa: mutual collaboration between HIV and cancer programs may provide timely research and public health data. Infect Agents Cancer. 2011;6:16.
Mendy M, Peterson I, Hossin S, et al. Observational study of vaccine efficacy 24 years after the start of hepatitis B vaccination in two Gambian villages: no need for a booster dose. PLoS One. 2013;8(3):e58029.
Mesri EA, Cesarman E, Boshoff C. Kaposi’s sarcoma and its associated herpesvirus. Nat Rev Cancer. 2010;10:707–19.
Mesri EA, Feitelson MA, Munger K. Human viral oncogenesis: a cancer hallmarks analysis. Cell Host Microbe. 2014;15:266–82.
Miyahara R, Jasseh M, Gomez P, et al. Barriers to timely administration of birth doses vaccines in the Gambia, West Africa. Vaccine. 2016;34(29):3335–41.
Molyneux EM, Rochford R, Griffin B, et al. Burkitt’s lymphoma. Lancet. 2012;379(9822):1234–44.
Munoz N, Bosch FX, De Sanjosé S, Tafur L, Izarzugaza I, Gili M, et al. The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int J Cancer. 1992;52(5):743–9.
Okuku F, et al. Infection-related cancers in sub-Saharan Africa: a paradigm for cancer prevention and control. Oncology. 2013;84:75–80.
Palacio-MejÃa LS, Range-Gomez G, Hernandez Avila M, et al. Cervical cancer, a disease of poverty: mortality difference between urban and rural areas in Mexico. Salud Publica Mex. 2003;45(Suppl 3):S315–25.
Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer. 2006;118(12):3030–44.
Parkin DM, Bray F, Ferlay J, Jemal A. Cancer in Africa 2012. Cancer Epidemiol Biomarkers Prev. 2014;23(6):953–66.
Plummer M, De Martel C, Ferlay J et al. Global burden of cancers attributable to infections in 2012: a synthentic analysis. Lancet Glob Health. 2016. doi:10.1016/S2214-109X(16)30143-7.
Sheweita SA, El-Shahat FG, Bazeed MA, Abu El-Maati MR, O’Connor PJ. Effects of schistosoma haematobium infection on drug-metabolizing enzymes in human bladder cancer tissues. Cancer Lett. 2004;205(1):15–21.
Sixbey JW, Nedrud JG, Raab-Traub N, Hanes RA, Pagano JS. Epstein-Barr virus replication in oropharyngeal epithelial cells. N Engl J Med. 1984;310(19):1225–30.
Smotkin D, Prokoph H, Wettstein FO. Oncogenic and nononcogenic human genital papillomaviruses generate the E7 mRNA by different mechanisms. J Virol. 1989;63(3):1441–7.
Teras LR, Rollison DE, Pawlita M, Michel A, Brozy J, de Sanjose S, Blase JL, Gapstur SM. Epstein-Barr virus and risk of non-Hodgkin lymphoma in the cancer prevention study-II and a meta-analysis of serologic studies. Int J Cancer. 2015;136(1):108–16.
Thompson MP, Kurzrock R. Epstein-Barr virus and cancer. Clin Cancer Res. 2004;10(3):803–21.
Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12–9.
WHO Global Health Observation Data Repository. 2015. http://apps.who.int/gho/data/view.main.22100?lang=en
Yosry A. Schistosomiasis and neoplasia. Contrib Microbiol. 2006;13:81–100.
Young LS, Rickinson AB. Epstein-Barr virus: 40 years on. Nat Rev Cancer. 2004;4(10):757–68.
Zucca E, Rohatiner A, Magrath I, Cavalli F. Epidemiology and management of lymphoma in low-income countries. Hematol Oncol. 2011;29(1):1–4.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Nnaji, M., Adedeji, O.A., Sule, O. (2017). Infection-Related Cancers in Sub-Saharan Africa. In: Adedeji, O. (eds) Cancer in Sub-Saharan Africa. Springer, Cham. https://doi.org/10.1007/978-3-319-52554-9_3
Download citation
DOI: https://doi.org/10.1007/978-3-319-52554-9_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-52553-2
Online ISBN: 978-3-319-52554-9
eBook Packages: MedicineMedicine (R0)